# Joseph K. Belanoff

> Joseph K. Belanoff is the co-founder, chief executive officer, president and a director of Corcept Therapeutics. An Amherst graduate who spent nine years on Wall Street before earning his M.D. at Columbia and training at Stanford, he has served as Corcept’s CEO and a director since 1999 and president since 2014. His professional story combines a return to business, a continuing Stanford affiliation and the development of an international academic collaboration network.

- **Role:** Co-Founder, Chief Executive Officer, President and Director at Corcept Therapeutics
- **Organizations:** Corcept Therapeutics, Stanford University
- **Education:** B.A., Amherst College, M.D., Columbia University College of Physicians & Surgeons, Residency training, Stanford University
- **Known for:** Co-founded Corcept Therapeutics and has served as CEO and a director since 1999., Led Corcept through its 2004 initial public offering., Added the presidency of Corcept in 2014.

## Career timeline

- **Before Columbia** — Spent nine years on Wall Street managing fixed-income trading desks and interest-rate arbitrage programs at three securities firms.
- **1992** — Beginning of positions at Stanford University documented in Corcept’s executive biography.
- **1998** — Co-founded Corcept Therapeutics; the company was incorporated in May.
- **1999** — Began service as chief executive officer and a director of Corcept.
- **2004** — Led Corcept during its April initial public offering; the offering raised approximately $49 million net.
- **2014** — Appointed president of Corcept in addition to CEO.
- **2020** — TEDxMontaVistaHighSchool talk, My Life Story, published in November.
- **2026** — Continues as CEO and president; company reported $256.1 million in second-quarter revenue.

## Achievements

- Co-founded Corcept Therapeutics and has served as CEO and a director since 1999.
- Led Corcept through its 2004 initial public offering.
- Added the presidency of Corcept in 2014.
- Developed a model of academic collaboration that requires publication of positive, negative and mixed findings.
- Maintains a Stanford adjunct professorship alongside corporate leadership.

## Latest updates

- **2026-09** — Corcept announced Justin Gunn would join the executive team and report to Belanoff, with new responsibilities effective October 1; Sean Maduck would remain a senior commercial advisor.
- **2026-07** — Corcept reported second-quarter revenue of $256.1 million, net income of $43.0 million, and raised 2026 revenue guidance to $1.1-$1.2 billion.
- **2026-05** — Appeared in a BiotechTV interview published May 30, 2026.

## Links

- Website: https://corcept.com/about/teams/joseph-belanoff/
- LinkedIn: https://www.linkedin.com/in/joe-belanoff-b240618

---

Profile page: https://yespress.io/joseph-belanoff
Published by YesPress — https://yespress.io
Last updated: 2026-10-20